These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells. Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231 [TBL] [Abstract][Full Text] [Related]
23. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment. Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211 [TBL] [Abstract][Full Text] [Related]
24. Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo. Liu M; Ju X; Willmarth NE; Casimiro MC; Ojeifo J; Sakamaki T; Katiyar S; Jiao X; Popov VM; Yu Z; Wu K; Joyce D; Wang C; Pestell RG Am J Pathol; 2009 May; 174(5):1910-20. PubMed ID: 19349372 [TBL] [Abstract][Full Text] [Related]
25. Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis. Schmelzle T; Mailleux AA; Overholtzer M; Carroll JS; Solimini NL; Lightcap ES; Veiby OP; Brugge JS Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3787-92. PubMed ID: 17360431 [TBL] [Abstract][Full Text] [Related]
26. Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin. Rohwer N; Welzel M; Daskalow K; Pfander D; Wiedenmann B; Detjen K; Cramer T Cancer Res; 2008 Dec; 68(24):10113-20. PubMed ID: 19074877 [TBL] [Abstract][Full Text] [Related]
27. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702 [TBL] [Abstract][Full Text] [Related]
28. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes. Gatza ML; Kung HN; Blackwell KL; Dewhirst MW; Marks JR; Chi JT Breast Cancer Res; 2011 Jun; 13(3):R62. PubMed ID: 21672245 [TBL] [Abstract][Full Text] [Related]
29. Oral administration of a gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression. So JY; Wahler JE; Yoon T; Smolarek AK; Lin Y; Shih WJ; Maehr H; Uskokovic M; Liby KT; Sporn MB; Suh N Cancer Prev Res (Phila); 2013 Sep; 6(9):959-70. PubMed ID: 23856074 [TBL] [Abstract][Full Text] [Related]
30. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene. Menendez JA; Vellon L; Oza BP; Lupu R J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079 [TBL] [Abstract][Full Text] [Related]
31. Loss of cell-matrix contact increases hypoxia-inducible factor-dependent transcriptional activity in glioma cells. Maurer GD; Brucker DP; Steinbach JP Biochem Biophys Res Commun; 2019 Jul; 515(1):77-84. PubMed ID: 31128911 [TBL] [Abstract][Full Text] [Related]
32. Lenticular cytoprotection. Part 1: the role of hypoxia inducible factors-1α and -2α and vascular endothelial growth factor in lens epithelial cell survival in hypoxia. Neelam S; Brooks MM; Cammarata PR Mol Vis; 2013; 19():1-15. PubMed ID: 23335846 [TBL] [Abstract][Full Text] [Related]
33. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis. McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838 [TBL] [Abstract][Full Text] [Related]
34. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma. Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163 [TBL] [Abstract][Full Text] [Related]
35. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Kim KK; Lee JJ; Yang Y; You KH; Lee JH Carcinogenesis; 2008 Apr; 29(4):704-12. PubMed ID: 18258606 [TBL] [Abstract][Full Text] [Related]
36. Anoikis molecular pathways and its role in cancer progression. Paoli P; Giannoni E; Chiarugi P Biochim Biophys Acta; 2013 Dec; 1833(12):3481-3498. PubMed ID: 23830918 [TBL] [Abstract][Full Text] [Related]
37. c-erbB2-induced disruption of matrix adhesion and morphogenesis reveals a novel role for protein kinase B as a negative regulator of alpha(2)beta(1) integrin function. Lindberg LE; Hedjazifar S; Baeckström D Mol Biol Cell; 2002 Aug; 13(8):2894-908. PubMed ID: 12181354 [TBL] [Abstract][Full Text] [Related]
38. Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis. Deng X; Li Q; Hoff J; Novak M; Yang H; Jin H; Erfani SF; Sharma C; Zhou P; Rabinovitz I; Sonnenberg A; Yi Y; Zhou P; Stipp CS; Kaetzel DM; Hemler ME; Yang XH Neoplasia; 2012 Aug; 14(8):678-89. PubMed ID: 22952421 [TBL] [Abstract][Full Text] [Related]
39. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells. Tammali R; Saxena A; Srivastava SK; Ramana KV J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240 [TBL] [Abstract][Full Text] [Related]